An increased hepatic NEFA influx through specific membrane translocases, such as CD36, eventually induces enhanced hepatic steatosis also in the NASH‐HCC mouse model in use, upon genetic OPN deletion. The gene discussed is SPP1; the disease is metabolic dysfunction-associated steatohepatitis.